MONACO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 17.310
EU - Europa 13.043
AS - Asia 9.181
SA - Sud America 1.193
Continente sconosciuto - Info sul continente non disponibili 327
AF - Africa 197
OC - Oceania 51
Totale 41.302
Nazione #
US - Stati Uniti d'America 16.816
RU - Federazione Russa 4.652
SG - Singapore 3.505
CN - Cina 3.052
GB - Regno Unito 2.815
IT - Italia 1.546
BR - Brasile 939
SE - Svezia 905
VN - Vietnam 724
HK - Hong Kong 718
FR - Francia 691
DE - Germania 628
IE - Irlanda 586
FI - Finlandia 559
KR - Corea 302
CA - Canada 249
UA - Ucraina 179
BD - Bangladesh 152
IN - India 140
TR - Turchia 94
AR - Argentina 90
JP - Giappone 85
BE - Belgio 84
ID - Indonesia 75
PL - Polonia 65
MX - Messico 57
NL - Olanda 57
ES - Italia 51
NG - Nigeria 50
IQ - Iraq 48
AU - Australia 45
AT - Austria 40
ZA - Sudafrica 40
EC - Ecuador 39
CR - Costa Rica 37
VE - Venezuela 31
CO - Colombia 30
IR - Iran 30
IL - Israele 29
SA - Arabia Saudita 28
SV - El Salvador 27
PK - Pakistan 25
CL - Cile 24
UZ - Uzbekistan 24
JM - Giamaica 19
LT - Lituania 19
JO - Giordania 18
NI - Nicaragua 18
EG - Egitto 17
CH - Svizzera 16
MA - Marocco 16
PH - Filippine 16
TT - Trinidad e Tobago 16
CW - ???statistics.table.value.countryCode.CW??? 14
GT - Guatemala 14
PR - Porto Rico 14
PY - Paraguay 14
TN - Tunisia 14
AZ - Azerbaigian 13
CZ - Repubblica Ceca 13
GR - Grecia 13
HN - Honduras 13
NO - Norvegia 13
HU - Ungheria 12
RO - Romania 12
BO - Bolivia 10
DO - Repubblica Dominicana 10
HR - Croazia 10
LB - Libano 10
LV - Lettonia 10
NP - Nepal 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
DZ - Algeria 9
RS - Serbia 9
BG - Bulgaria 8
DK - Danimarca 8
KZ - Kazakistan 8
PE - Perù 8
KE - Kenya 7
OM - Oman 7
TG - Togo 7
TW - Taiwan 7
UY - Uruguay 7
KG - Kirghizistan 6
GP - Guadalupe 5
KH - Cambogia 5
MY - Malesia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
PT - Portogallo 5
SC - Seychelles 5
TH - Thailandia 5
AM - Armenia 4
BS - Bahamas 4
CI - Costa d'Avorio 4
EE - Estonia 4
LA - Repubblica Popolare Democratica del Laos 4
LI - Liechtenstein 4
LU - Lussemburgo 4
Totale 40.914
Città #
Southend 2.318
Ashburn 2.250
Singapore 1.830
Chandler 1.605
Moscow 1.584
San Jose 1.472
Dallas 1.200
Jacksonville 1.134
Woodbridge 831
Ann Arbor 710
Hong Kong 707
Verona 605
Dublin 578
Beijing 543
Houston 503
Council Bluffs 483
The Dalles 419
New York 362
Los Angeles 297
Wilmington 250
Lawrence 232
Princeton 232
Jinan 224
Ho Chi Minh City 215
Nanjing 205
Buffalo 167
Helsinki 167
Hebei 152
Shenyang 145
Santa Clara 141
Hanoi 139
Munich 119
Tianjin 113
São Paulo 106
Milan 104
Columbus 102
Ningbo 87
Redondo Beach 87
Sindelfingen 86
Zhengzhou 81
Brussels 80
Changsha 80
Montreal 79
Nanchang 77
Lancaster 76
Tokyo 75
Boardman 72
Haikou 72
Redmond 70
Turku 70
Rome 69
Chicago 65
Dearborn 65
Guangzhou 65
Seattle 62
Orem 61
Seoul 60
Washington 60
Taizhou 59
Hangzhou 58
Dong Ket 54
London 54
Warsaw 53
Toronto 52
Jakarta 51
Redwood City 51
Brooklyn 49
Jiaxing 49
Denver 47
Carrboro 46
Falls Church 45
Taiyuan 44
Abuja 43
San Francisco 43
Atlanta 41
Istanbul 40
Stockholm 40
Fairfield 39
Norwalk 39
Fuzhou 38
Chennai 37
Frankfurt am Main 36
Bologna 35
Boston 35
Haiphong 32
Las Vegas 32
Rio de Janeiro 32
San José 31
Da Nang 30
Phoenix 30
Lanzhou 28
Nuremberg 27
Amsterdam 26
Philadelphia 26
Paris 25
Belo Horizonte 24
Lappeenranta 24
Johannesburg 23
Providence 23
San Salvador 23
Totale 25.457
Nome #
La biopsia del nervo periferico. Indicazioni, metodiche e principali quadri patologici [Peripheral nerve biopsy. Indications, methods and principal pathological pictures] 288
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 282
Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker Disease with the P102L mutation. 281
AUMENTATA ESPRESSIONE DEL GENE COX-2 NEL SANGUE PERIFERICO DI PAZIENTI CON ICTUS ISCHEMICO 280
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 279
Increased levels of CSF heart-type fatty acid-binding protein and tau protein after aneurysmal subarachnoid hemorrhage. 276
Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy 274
Acute inflammatory demyelinating polyneuropathy as a manifestation of chronic lymphoproliferative disorder of NK cells. 266
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 265
Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples 264
Accuracy of diagnostic criteria for sporadic Creutzfeldt-Jakob disease among rapidly progressive dementia. 258
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 251
AZT-induced mitochondrial myopathy 250
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 248
Antisulfatide polyneuropathy: antibody-mediated complement attack on peripheral myelin 245
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 242
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 240
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 236
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 232
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 231
Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale 231
A 49-year-old man with neuropsychiatric symptoms followed by progressive cognitive decline. 229
Intravenous immunoglobulin for post-polio syndrome: a randomized double-blind, placebo-controlled study 229
Lesione bilaterale della corteccia cingolata anteriore: studio polisonnografico ad autonomico di un caso. 228
[Hypertrophic neuropathies beginning in infancy: a study of 3 cases (author's transl)] 224
Cognitive onset in multiple sclerosis 224
A test for Creutzfeldt-Jakob disease using nasal brushings. 224
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 224
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 224
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 224
Molecular analysis of iatrogenic scrapie in Italy 222
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 222
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 221
Adult-onset migraine-related ophthalmoplegia and omolateral fetal-type posterior cerebral artery. 221
A case of acute fulminant multiple sclerosis treated with alemtuzumab 221
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 220
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 219
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma. 219
Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease 218
Time for a Consensus Conference on pain in neurorehabilitation 218
Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. 218
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 217
Brentuximab vedotin: axonal microtubule's Apollyon 216
Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping 215
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 215
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies 215
Risk factors for post-polio syndrome among an Italian population: a case-control study. 214
Paroxysmal dysarthria-ataxia in remitting-relapsing Bickerstaff's-like encephalitis. 214
Binding of monoclonal anti-myelin-associated glycoprotein antibodies to human foetal peripheral neurons in culture 212
Cytoskeletal changes in cultured human fibroblasts following exposure to 2,5-hexanedione 211
Unusual case of solitary intraparenchymal brain plasmacytoma. 210
High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD 210
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 209
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 208
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 208
RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy 208
Immunoaffinity reactors for prion protein qualitative analysis 207
The proteome: anno Domini 2002 206
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 206
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 206
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 204
Neurodegeneration-associated proteins in human olfactory neurons collected by nasal brushing 202
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 202
Convergent pathological and ultrasound features in hereditary syndromic and non‐syndromic minifascicular neuropathy related to DHH 202
Association of prolonged QTc interval with Takotsubo cardiomyopathy: A neurocardiac syndrome inside the mystery of the insula of Reil 200
The dispersion of myocardial repolarization in ischemic stroke and intracranial hemorrhage 199
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 199
Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. 196
Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease 195
Nervous system: subclinical target of SARS-CoV-2 infection 195
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 194
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 194
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 194
Intraspecies transmission of BASE induces clinical dullness and amyotrophic changes 193
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 192
QTc Prolongation in Patients with Dementia and Mild Cognitive Impairment: Neuropsychological and Brain Imaging Correlations 192
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson's disease 190
Cerebral amyloidoses: molecular pathways and therapeutic challenges 190
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 190
Epilepsy in multiple sclerosis: The role of temporal lobe damage 189
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 188
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 188
Response to Nagai et al. 186
Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia 185
Spectral analysis of cardiovascular responses in POTS 185
Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. 184
Specific and surrogate cerebrospinal fluid markers in Creutzfeldt–Jakob Disease (chapter 17) 183
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 182
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 182
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 181
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype 180
Friedreich's ataxia. A light- and electron microscopic study of peripheral nerve biopsies 179
Inherited neuroaxonal dystrophy in C6 deficient rabbits 179
Hexacarbon axonopathy: the morphological expression of altered cytoskeletal translocation. 179
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 179
Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis 178
Biochemical characterization of prions 178
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 178
Bovine spongiform encephalopathy. (chapter 1) 177
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 177
Totale 21.415
Categoria #
all - tutte 141.270
article - articoli 132.913
book - libri 0
conference - conferenze 3.246
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.111
Totale 282.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.273 0 0 0 275 50 110 32 111 65 67 149 414
2022/20234.226 306 483 379 745 384 971 35 307 432 22 103 59
2023/20242.063 80 163 179 215 272 467 78 120 19 129 218 123
2024/20255.162 277 357 226 840 259 195 240 259 802 301 430 976
2025/202615.353 1.085 871 1.134 2.333 3.892 1.052 1.363 808 1.216 916 289 394
2026/20272.972 197 373 631 1.771 0 0 0 0 0 0 0 0
Totale 41.302